Loading insider details...
Beta
Latest Form 4 (Jul 7, 2026): Sale of 200 REGN shares, $130.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 7, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 200 | $130.0K |
| May 4, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 5 | $3.5K |
| Apr 3, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 1 | $771.32 |
| Mar 3, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 7 | $5.4K |
| Feb 11, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 1 | $775.63 |
| Jan 6, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 155 | n/a |
| Jan 6, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 166 | n/a |
| Oct 3, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 3 | $3.1K |
| Sep 5, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 4 | $4.7K |
| Aug 5, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 1 | $1.1K |